A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
The clear liquid that shot out toward leaves and debris alike was a citrus-based fire retardant called ... the early stages of selling cities on the spray, according to records filed with the ...
Curtis was prescribed several different steroid sprays that help clear nasal congestion but without the risk of ‘rebound congestion’ - but nothing helped. Due to pandemic-related delays ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bumetanide nasal spray (RSQ-777) for the treatment of edema associated with congestive heart failure, ...